Exosome Hair Serums: What Dermatologists Say Actually Works
No exosome product has FDA approval, yet exosome hair serums are multiplying on shelves. Three physicians explain the evidence, the safety gaps, and what to check before buying.
Topic: Hair Loss
Bempikibart Cut Hair Loss Scores 35.3% in Alopecia Areata Trial
Q32 Bio's bempikibart cut SALT hair-loss scores by 35.3 percent at week 36, with 40 percent of severe alopecia areata patients reaching SALT-20 — even after failing JAK inhibitors.
